PDSB PDS Biotechnology Corporation
$0.29▼ -6.47%
Healthcare
Other
After hours
$0.29▼ -2.64%
Sep 11, 7:59 PM ET
Volume 5.67M
Avg Volume (10D) 53.43M
Key Metrics & Fundamentals
Market Cap
$16.51M
P/E Ratio
–
Div Yield
–%
52W Range
0.20 - 1.55
% vs 50 MA
-41.99%
% vs 200 MA
-63.26%
RSI-14
42.6
MACD Histogram
+0.0300
Beta (1Y vs SPY)
2.85
Free Cash Flow
-$2.79M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.36M
COGS
–
Operating Exp
$6.50M
Operating Income
-$6.50M
EBIT
-$6.50M
Pretax Income
-$9.75M
Net Income
-$9.75M
EPS (Diluted)
-0.18
Price & Volume History
Loading chart…
Recent News
BC-Most Active Stocks
Associated Press · Sep 8, 2026 2:30 PM
PDS Biotechnology Raises $22.6 Million in Equity Funding; Shares Rise
MT Newswires · Sep 8, 2026 2:26 PM
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
GlobeNewswire · Sep 8, 2026 12:30 PM
PDS Biotechnology: Q2 Earnings Snapshot
Associated Press · Aug 13, 2026 12:38 PM
PDS Biotech Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 13, 2026 12:30 PM
PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101
GlobeNewswire · Aug 11, 2026 12:25 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PDSB's money flow as a full page
Social Sentiment
Avg +0.75 · 2 posts
DDPriceTargetPDSB is $1.56 and it might be the last time you ever see it this low. This is your moonshot.
r/options · Jun 6, 2025
The post presents PDSB as a high-potential investment with significant price target estimates and a bullish outlook.
very_positive
+0.90
$PDSB is consolidating before bullish action. Next catalyst Nov 27-30th.
r/stocks · Nov 11, 2024
The post presents a cautiously optimistic view of PDSB's development pipeline and strategic collaborations, suggesting potential growth.
positive
+0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.